Table of Contents

company-logo

Vicore Pharma Holding AB (publ) engages in the research and development of pharmaceutical products for the treatments for rare lung diseases. The company is developing VP01, a small molecule compound for oral administration that is in phase II clinical trial for the treatment of interstitial lung diseases, idiopathic pulmonary fibrosis (IPF), systemic sclerosis, and COVID-19; and VP02, a formulation and delivery route for an existing immunomodulatory compound, which is preclinical trials to treat patients with IPF. It has a cooperation and development agreement with Emeriti Bio AB; license agreement with Nanologica AB (publ); and a collaboration agreement with Alex Therapeutics AB for the development and clinical validation of a digital therapeutic (DTx) built on the Alex DTx platform. The company was formerly known as Mintage Scientific AB. Vicore Pharma Holding AB (publ) was founded in 2000 and is headquartered in Gothenburg, Sweden.

Vicore Pharma Dividend Announcement

• Vicore Pharma does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Vicore Pharma dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Vicore Pharma Dividend History

Vicore Pharma Dividend Yield

Vicore Pharma current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Vicore Pharma stock? Use our calculator to estimate your expected dividend yield:

Vicore Pharma Financial Ratios

P/E ratio-4.60
PEG ratio-0.09
P/B ratio2.39
ROE-44.73%
Payout ratio0.00%
Current ratio14.27
Quick ratio14.27
Cash Ratio11.80

Vicore Pharma Dividend FAQ

Does Vicore Pharma stock pay dividends?
Vicore Pharma does not currently pay dividends to its shareholders.
Has Vicore Pharma ever paid a dividend?
No, Vicore Pharma has no a history of paying dividends to its shareholders. Vicore Pharma is not known for its dividend payments.
Why doesn't Vicore Pharma pay dividends?
There are several potential reasons why Vicore Pharma would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Vicore Pharma ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Vicore Pharma has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Vicore Pharma a dividend aristocrat?
Vicore Pharma is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Vicore Pharma a dividend king?
Vicore Pharma is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Vicore Pharma a dividend stock?
No, Vicore Pharma is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Vicore Pharma stocks?
To buy Vicore Pharma you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Vicore Pharma stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.